Julian Chick
Chairman bei CANN GROUP LIMITED
Profil
Julian J.
Chick is currently the Chairman at Cann Group Ltd.
He also holds positions as a Director at Mid-Atlantic BioTherapeutics, Inc. and as an Independent Non-Executive Director at LTR Pharma Ltd.
Previously, he served as the Chief Executive Officer & Director at Tali Digital Ltd.
from 2004 to 2010.
He was also the Chief Operating Officer & Director at Anteris Technologies Ltd.
Additionally, he worked as a Non-Executive Director at Opyl Ltd.
from 2019 to 2023.
Dr. Chick holds a doctorate degree from the University of Oxford and an undergraduate degree from LaTrobe University.
Aktive Positionen von Julian Chick
Unternehmen | Position | Beginn |
---|---|---|
CANN GROUP LIMITED | Chairman | 28.08.2023 |
LTR PHARMA LIMITED | Director/Board Member | - |
Mid-Atlantic BioTherapeutics, Inc.
Mid-Atlantic BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mid-Atlantic BioTherapeutics, Inc. is a clinical-stage pharmaceutical company focused on the clinical development and commercialization of a novel anti-infective therapeutic approach, which is immunotherapy for infectious diseases. The company was founded by David Horn, David Jobes, and Jean-Pierre Gagnon in 2011 and is headquartered in Doylestown, PA. | Director/Board Member | - |
Ehemalige bekannte Positionen von Julian Chick
Unternehmen | Position | Ende |
---|---|---|
OPYL LIMITED | Chairman | 16.09.2022 |
TALI DIGITAL LIMITED | Chief Executive Officer | 31.05.2010 |
ANTERIS TECHNOLOGIES LTD | Chief Operating Officer | - |
Ausbildung von Julian Chick
University of Oxford | Doctorate Degree |
LaTrobe University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 5 |
---|---|
TALI DIGITAL LIMITED | Technology Services |
ANTERIS TECHNOLOGIES LTD | Health Technology |
OPYL LIMITED | Technology Services |
CANN GROUP LIMITED | Process Industries |
LTR PHARMA LIMITED | Health Technology |
Private Unternehmen | 1 |
---|---|
Mid-Atlantic BioTherapeutics, Inc.
Mid-Atlantic BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mid-Atlantic BioTherapeutics, Inc. is a clinical-stage pharmaceutical company focused on the clinical development and commercialization of a novel anti-infective therapeutic approach, which is immunotherapy for infectious diseases. The company was founded by David Horn, David Jobes, and Jean-Pierre Gagnon in 2011 and is headquartered in Doylestown, PA. | Commercial Services |